UK-EU talks target 'win-win' outcome on vaccine supplies

25 March 2021
brexit_big

A joint statement from the UK government and the European Union signals the latest attempt to draw a line under a long-running dispute over vaccine supplies in Europe.

The UK and EU said they have been “discussing what more we can do to ensure a reciprocally beneficial relationship between the UK and EU on COVID-19.”

In February, with the vaccine rollout proceeding slowly in Europe, officials threatened to block exports from the 27-nation trading bloc, raising concerns over so-called “vaccine nationalism.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory

Companies featured in this story

More ones to watch >


More Features in Biotechnology